The COVID-19 PPE Distribution cartoon illustrates the confusion and complexity of distributing Personal Protective Equipment (PPE) to defend…
On Jun. 25, 2021, researchers from the University of Oxford released their findings about the so-called ”correlates of…
On Jun. 25, 2021, Roche announced that the Food and Drug Administration (FDA) had issued an Emergency Use…
On Jun. 23, 2021, Biogen and Eisai announced that the U.S. Food and Drug Administration (FDA) had granted…
On Jun. 23, 2021, the National Institutes of Health (NIH) announced that an observational study had begun to…
On Jun. 22, 2021, National Institutes of Health researchers reported that the prevalence of COVID-19 in the U.S….
On Jun. 22, 2021, Moderna announced that the European Commission (EC) had purchased an additional 150 million doses…
On Jun. 22, 2021, BioReference Laboratories, an OPKO Health company, announced a COVID-19 testing program for U.S. based…
On Jun. 22, 2021, the National Research Council of Canada (NRC) announced it had completed construction of the…
On Jun. 21, 2021, Gilead Sciences announced positive data from three retrospective studies of the real-world treatment of…
On Jun. 21, 2021, Cumberland Pharma released a series of case reports describing the effectiveness of Vibativ (telavancin)…
On Oct. 6, 2021, the World Health Organization (WHO) and its COVAX partners are working with a South…
On Jun. 19, 2021, the Ebola outbreak that emerged in Guinea in mid-February was declared over. It was…
On Jun. 17, 2021, the U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation and Research granted…
On Jun. 16, 2021, the University of Oxford announced the Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial demonstrated…
On Jun. 16, 2021, Moderna announced that the U.S. government had purchased an additional 200 million doses of…
On Jun. 16, 2021, Moderna announced that the U.S. government had purchased an additional 200 million doses of…
On Jun. 16, 2021, Pfizer and The Academic Research Organization (ARO) from the Hospital Israelita Albert Einstein announced…
On Jun. 15, 2021, Moderna and Magenta Investments, an industrial conglomerate in the United Arab Emirates (UAE), announced…
On Jun. 14, 2021, Moderna announced that it had submitted an authorization application to Swissmedic for use of…
On Jun. 14, 2021, University of British Columbia researchers Dr. Jayachandran Kizhakkedathu, Dr. Caigan Du and Dr. Christopher…
On Jun. 14, 2021, Novavax announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, demonstrated 100% protection against…
On Jun. 14, 2021, Novavax announced data from the first co-administration study of a SARS-CoV-2 vaccine candidate [Novavax,…
On Jun. 14, 2021, Cocrystal Pharma announced that its lead preclinical SARS-CoV-2 3CL protease inhibitor CDI-45205 is active…
On Jun. 14, 2021, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced that was recruiting volunteers in the…
On Jun. 13, 2021, in a landmark agreement at G7 summit, held in Cornwall, UK, global leaders have…
On Jun. 11, 2021, Quidel announced today that it had received an amended Emergency Use Authorization (EUA) from…
On Jun. 11, 2021, Moderna and and Tabuk Pharmaceutical Manufacturing Company (a fully owned subsidiary of Astra Industrial…
On Jun. 11, 2021, The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for…
On Jun. 11, 2021, Novavax announced preclinical and clinical data on the company’s original recombinant protein COVID-19 vaccine…